Suzanne Bujara

Because standardized approaches for echocardiographic screening are impractical for certain subgroups of people with congenital heart disease, experts offered screening adaptations for pulmonary hypertension.

Despite the frequency with which it occurs, familial hypercholesterolemia often goes undiagnosed, with only 10% of affected patients aware of this genetic disorder.

Screening for cardiovascular disease risk is recommended for clinicians who manage patients with bipolar disorder.

Statin therapy is the first line of defense against high LDL-C and the risk for atherosclerotic cardiovascular disease, the leading cause of morbidity and mortality in individuals with diabetes.

Nutraceuticals may offer a solution to patients who cannot tolerate statins because of severe muscle pain.

Although COPD has been identified as a risk factor for cardiovascular disease, researchers are less certain about the relationship between COPD and stroke.

Recent evidence suggests that systemic sclerosis and systemic lupus erythematosus comorbid with pulmonary arterial hypertension should be considered separate diseases.

Despite public perception that cannabis is “natural” and “safe,” it has been implicated in many serious cardiovascular events, even in young, otherwise healthy people.

Future clinical trials on pulmonary arterial hypertension should include patients from diverse racial and ethnic backgrounds.

The ratio of hemodynamic markers derived from right heart catheterization can predict treatment outcomes in patients with pulmonary hypertension.